Background: One of the most prominent neurobiological models of alexithymia assumes an altered function of the anterior cingulate cortex (ACC) as the crucial neural correlate of alexithymia. So far functional imaging studies have yielded inconclusive results. Therefore, we tested this hypothesis in healthy alexithymics and nonalexithymics in an event-related fMRI study. Methods: Thirty high- and 30 low-alexithymic right-handed male subjects (selected by the 20-item Toronto Alexithymia Scale, TAS-20) were investigated with event-related fMRI using a picture viewing paradigm. The stimuli consisted of happy, fearful and neutral facial expressions (Ekman-Friesen) as well as positive, negative and neutral pictures from the International Affective Picture System. Results: Contrasting the high-alexithymic with the low-alexithymic group we observed increased activation of the supragenual ACC for different emotional valences as well as for different emotional stimuli. Moreover, there was a positive correlation of the ACC with the individual TAS-20 scores but no correlations with the individual Beck Depression Inventory scores. Additionally, there was no difference in activity of the amygdala. Conclusions: We demonstrated that the supragenual ACC is constantly activated more strongly in alexithymic subjects and that this activation is related to the symptoms of alexithymia and not to associated symptoms such as depression. Therefore, our findings support the hypothesis of an altered function of the ACC in alexithymia.

1.
Bagby RM, Taylor GJ, Parker JD: The Twenty-Item Toronto Alexithymia Scale–II: convergent, discriminant, and concurrent validity. J Psychosom Res 1994;38:33–40.
2.
Franz M, Schaefer R, Schneider C, Sitte W, Bachor J: Visual event-related potentials in subjects with alexithymia: modified processing of emotional aversive information? Am J Psychiatry 2004;161:728–735.
3.
Taylor GJ: Recent developments in alexithymia theory and research. Can J Psychiatry 2000;45:134–142.
4.
Dorard G, Berthoz S, Phan O, Corcos M, Bungener C: Affect dysregulation in cannabis abusers: a study in adolescents and young adults. Eur Child Adolesc Psychiatry 2008;17:274–282.
5.
Honkalampi K, Hintikka J, Tanskanen A, Lehtonen J, Viinamaki H: Depression is strongly associated with alexithymia in the general population. J Psychosom Res 2000;48:99–104.
6.
Larsen JK, Brand N, Bermond B, Hijman R: Cognitive and emotional characteristics of alexithymia: a review of neurobiological studies. J Psychosom Res 2003;54:533–541.
7.
Taylor GJ, Bagby RM: New trends in alexithymia research. Psychother Psychosom 2004;73:68–77.
8.
Kano M, Fukudo S, Gyoba J, Kamachi M, Tagawa M, Mochizuki H, Itoh M, Hongo M, Yanai K: Specific brain processing of facial expressions in people with alexithymia: an H215O-PET study. Brain 2003;126:1474–1484.
9.
Lane RD, Ahern GL, Schwartz GE, Kaszniak AW: Is alexithymia the emotional equivalent of blindsight? Biol Psychiatry 1997;42:834–844.
10.
Lane RD, Reiman EM, Axelrod B, Yun LS, Holmes A, Schwartz GE: Neural correlates of levels of emotional awareness: evidence of an interaction between emotion and attention in the anterior cingulate cortex. J Cogn Neurosci 1998;10:525–535.
11.
McRae K, Reiman EM, Fort CL, Chen K, Lane RD: Association between trait emotional awareness and dorsal anterior cingulate activity during emotion is arousal-dependent. Neuroimage 2008;41:648–655.
12.
Posner MI, Rothbart MK: Attention, self-regulation and consciousness. Philos Trans R Soc Lond B Biol Sci 1998;353:1915–1927.
13.
Reiman EM, Lane RD, Ahern GL, Schwartz GE, Davidson RJ, Friston KJ, Yun LS, Chen K: Neuroanatomical correlates of externally and internally generated human emotion. Am J Psychiatry 1997;154:918–925.
14.
Eslinger PJ, Damasio AR: Severe disturbance of higher cognition after bilateral frontal lobe ablation: patient EVR. Neurology 1985;35:1731–1741.
15.
Eslinger PJ: Neurological and neuropsychological bases of empathy. Eur Neurol 1998;39:193–199.
16.
Hornak J, Bramham J, Rolls ET, Morris RG, O’Doherty J, Bullock PR, Polkey CE: Changes in emotion after circumscribed surgical lesions of the orbitofrontal and cingulate cortices. Brain 2003;126:1691–1712.
17.
Schafer R, Popp K, Jorgens S, Lindenberg R, Franz M, Seitz RJ: Alexithymia-like disorder in right anterior cingulate infarction. Neurocase 2007;13:201–208.
18.
Shamay-Tsoory SG, Tomer R, Goldsher D, Berger BD, Haron-Peretz J: Impairment in cognitive and affective empathy in patients with brain lesions: anatomical and cognitive correlates. J Clin Exp Neuropsychol 2004;26:1113–1127.
19.
Aleman A: Feelings you can’t imagine: towards a cognitive neuroscience of alexithymia. Trends Cogn Sci 2005;9:553–555.
20.
Berthoz S, Artiges E, Van De Moortele PF, Poline JB, Rouquette S, Consoli SM, Martinot JL: Effect of impaired recognition and expression of emotions on frontocingulate cortices: an fMRI study of men with alexithymia. Am J Psychiatry 2002;159:961–967.
21.
Leweke F, Stark R, Milch W, Kurth R, Schienle A, Kirsch P, Stingl M, Reimer C, Vaitl D: Patterns of neuronal activity related to emotional stimulation in alexithymia. Psychother Psychosom Med Psychol 2004;54:437–444.
22.
Kugel H, Eichmann M, Dannlowski U, Ohrmann P, Bauer J, Arolt V, Heindel W, Suslow T: Alexithymic features and automatic amygdala reactivity to facial emotion. Neurosci Lett 2008;435:40–44.
23.
Reker M, Ohrmann P, Rauch AV, Kugel H, Bauer J, Dannlowski U, Arolt V, Heindel W, Suslow T: Individual differences in alexithymia and brain response to masked emotion faces. Cortex 2010;46:658–667.
24.
Beck AT, Steer RA, Brown GK: Beck Depression Inventory – Second Edition (manual). San Antonio, Psychological Corporation, 1996.
25.
Bach M, Bach D, de ZM, Serim M, Bohmer F: Validation of the German version of the 20-item Toronto Alexithymia Scale in normal persons and psychiatric patients. Psychother Psychosom Med Psychol 1996;46:23–28.
26.
Bagby RM, Taylor GJ, Parker JD: Construct validity of the Toronto Alexithymia Scale. Psychother Psychosom 1988;50:29–34.
27.
Bagby RM, Parker JD, Taylor GJ: The twenty-item Toronto Alexithymia Scale-I: item selection and cross-validation of the factor structure. J Psychosom Res 1994;38:23–32.
28.
Franz M, Popp K, Schaefer R, Sitte W, Schneider C, Hardt J, Decker O, Braehler E: Alexithymia in the German general population. Soc Psychiatry Psychiatr Epidemiol 2008;43:54–62.
29.
Parker JD, Taylor GJ, Bagby RM: Alexithymia and the recognition of facial expressions of emotion. Psychother Psychosom 1993;59:197–202.
30.
Kuhner C, Burger C, Keller F, Hautzinger M: Reliability and validity of the Revised Beck Depression Inventory (BDI-II): results from German samples. Nervenarzt 2007;78:651–656.
31.
Oldfield RC: The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971;9:97–113.
32.
Ekman P, Friesen WV: Pictures of Facial Affect. Palo Alto, Consulting Psychologists Press, 1976.
33.
Lang PJ, Bradley MM, Cuthbert BN: International Affective Picture System (IAPS). Instruction Manual and Affective Ratings. Center for Research in Psychophysiology University of Florida (rep No A-4). Gainesville, University of California, 1999.
34.
Heinzel A, Bermpohl F, Niese R, Pfennig A, Pascual-Leone A, Schlaug G, Northoff G: How do we modulate our emotions? Parametric fMRI reveals cortical midline structures as regions specifically involved in the processing of emotional valences. Brain Res Cogn Brain Res 2005;25:348–358.
35.
Grimm S, Schmidt CF, Bermpohl F, Heinzel A, Dahlem Y, Wyss M, Hell D, Boesiger P, Boeker H, Northoff G: Segregated neural representation of distinct emotion dimensions in the prefrontal cortex – an fMRI study. Neuroimage 2006;30:325–340.
36.
Schneider F, Bermpohl F, Heinzel A, Rotte M, Walter M, Tempelmann C, Wiebking C, Dobrowolny H, Heinze HJ, Northoff G: The resting brain and our self: self-relatedness modulates resting state neural activity in cortical midline structures. Neuroscience 2008;157:120–131.
37.
Stocker T, Kellermann T, Schneider F, Habel U, Amunts K, Pieperhoff P, Zilles K, Shah NJ: Dependence of amygdala activation on echo time: results from olfactory fMRI experiments. Neuroimage 2006;30:151–159.
38.
Friston KJ, Frith CD, Turner R, Frackowiak RS: Characterizing evoked hemodynamics with fMRI. Neuroimage 1995;2:157–165.
39.
Worsley KS: Instability of localisation of cerebral blood flow activation foci with parametric maps. J Cereb Blood Flow Metab 1993;13:1041–1042.
40.
Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH: An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003;19:1233–1239.
41.
Lane RD, Reiman EM, Axelrod B, Yun LS, Holmes A, Schwartz GE: Neural correlates of levels of emotional awareness: evidence of an interaction between emotion and attention in the anterior cingulate cortex. J Cogn Neurosci 1998;10:525–535.
42.
Hornak J, Bramham J, Rolls ET, Morris RG, O’Doherty J, Bullock PR, Polkey CE: Changes in emotion after circumscribed surgical lesions of the orbitofrontal and cingulate cortices. Brain 2003;126:1691–1712.
43.
Meriau K, Wartenburger I, Kazzer P, Prehn K, Lammers CH, van der ME, Villringer A, Heekeren HR: A neural network reflecting individual differences in cognitive processing of emotions during perceptual decision making. Neuroimage 2006;33:1016–1027.
44.
Karlsson H, Naatanen P, Stenman H: Cortical activation in alexithymia as a response to emotional stimuli. Br J Psychiatry 2008;192:32–38.
45.
Wright CI, Fischer H, Whalen PJ, McInerney SC, Shin LM, Rauch SL: Differential prefrontal cortex and amygdala habituation to repeatedly presented emotional stimuli. Neuroreport 2001;12:379–383.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.